Germany bans Ranbaxy drug; GlaxoSmithKline best at getting drugs to the poor; Congress to cut funds to those who use pumps instead of Viagra;

@FiercePharma: IMS: Rebates, discounts could take an $80B bite out of U.S. drug spending through 2018. Story | Follow @FiercePharma

@CarlyHFierce: J&J looks for Xarelto boost in real-world cost data. Article | Follow @CarlyHFierce

> Germany has banned over quality issues a Ranbaxy Laboratories drug made at one of the plants already prevented from shipping to the U.S. Story

> GlaxoSmithKline ($GSK) again tops the list of companies that make drugs available to the poor. Story

> Novartis' ($NVS) chronic obstructive pulmonary disease drug Ultibro has been launched in the UK by marketing partner Pfizer ($PFE). Report

Biotech News

@FierceBiotech: Bayer tees up its new #hemophilia drug for an @US_FDA submission. More | Follow @FierceBiotech

@JohnCFierce: Busy biotechs bag $121M in VC cash. Article | Follow @JohnCFierce

@DamianFierce: Considering @GenzymeCorp's party for Cerdelga, how big was the Lemtrada cake? More | Follow @DamianFierce

> Naurex bags an $80M round for PhIII study of an NMDA drug for depression. Article

> Puma tanks on a fresh setback for its breast cancer drug. News

Medical Device News

@FierceMedDev: Edison Nation and Mount Sinai team up for device innovation. More | Follow @FierceMedDev

@EmilyWFierce: Tax-inversion loophole likely to cost the government $2.2B in lost tax revenue next year. Story | Follow @EmilyWFierce

> Illumina and Sequenom lay prenatal diagnostic patent feud to rest. More

> New study supports effectiveness of 3-D breast cancer mammography. News

> Xeltis gets $34M to develop biodegradable heart valves and vessels. Article

Drug Delivery News

> DBV's peanut allergy patch tests well, boosting its market value to almost $1B. Report

> Valerion teams up with Catalent to develop orphan drug delivery tech. News

> Recipharm purchases Flamel facility with delivery partnership. Story

> U.S. Army deploys a novel topical antiseptic to fight ebolavirus. Article

> NIH grants $20M to develop an intravaginal ring to prevent HIV. More

Diagnostics News

> Cepheid wins FDA nod for norovirus test. Report

> Germany's nanoPET partners with Boehringer Ingelheim for imaging Dx deal. News

> Philips gets FDA approval for spectral imaging system. Story

> Roche dives into prenatal Dx space with Ariosa purchase. Item

> U.K. and Wellcome Trust back trial of new, 15-minute Ebola test in West Africa. Article

Pharma Marketing News

> PhIII failure dashes Novartis' hopes of Gilenya label expansion. Report

> Reports: BMS whittles China sales operation by 1,000. More

> J&J looks for Xarelto boost in real-world cost data. Story

> Pfizer believes a dose of confidence will help it sell biosimilars. Link

> IMS: Rebates, discounts could take an $80B bite out of U.S. drug spending through 2018. Article

And Finally... The U.S. Congress may stop an estimated $444 million in Medicare spending for vacuum pumps used to treat erectile dysfunction often used by men who can't afford drugs like Viagra. Story

Suggested Articles

Look out, diabetes market: Novo Nordisk won its FDA nod for highly anticipated Rybelsus to control blood sugar in patients with Type 2 diabetes.

Insys is in fire sale mode as part of its bankruptcy plan, and now it’s been given the go-ahead to sell the opioid that helped get it there.

GSK CEO Emma Walmsley could soon have a new title: Microsoft board member. The software giant has nominated her to its board of directors.